Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis

Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis

$ 3999

Spain's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $352 Mn in 2022 and is estimated to expand at a CAGR of 6.1% from 2022 to 2030 and will reach $566 Mn in 2030. One of the main reasons propelling the growth of this market is the ageing population and government initiatives. The market is segmented by drug class and by distribution channel. Some key players in this market are Bioiberica, Ferrer, Laboratorios Esteve, Chiesi España, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Spain Limited and others.

ID: IN10ESPH410 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Nandini Shah

Buy Now

Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Executive Summary

The Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market was valued at $352 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $566 Mn in 2030. Airflow restriction and partial irreversibility are hallmarks of the potentially preventable chronic respiratory condition known as chronic obstructive pulmonary disease (COPD). By 2030, COPD is expected to overtake all other causes of death to become the third-leading cause of death globally. Not just in low-income nations, but also in high-income nations with a rising older population, is COPD more prevalent. The prevalence of COPD is anticipated to increase by 29% in Spain by 2030 as a result of the country's changing demographics. The primary risk factor for COPD is cigarette smoking, which is followed by indoor and outdoor air pollution, workplace dangers, and respiratory infections.

Spain COPD Therapeutics Market

Market Dynamics

Market Growth Drivers

COPD is a chronic disease that is becoming increasingly prevalent in Spain, mainly due to smoking and environmental pollution. According to a report by the Spanish Society of Pulmonology and Thoracic Surgery, around 10% of the Spanish population suffers from COPD, and this figure is expected to rise in the coming years. This increasing prevalence is a significant growth driver for the COPD therapeutics market in Spain. The elderly population in Spain is increasing, and this demographic is more susceptible to COPD. Around 20% of the Spanish population was aged 65 or older, and this percentage is expected to increase in the coming years.

As the elderly population increases, the demand for COPD therapeutics is also expected to rise, driving the market growth. With advancements in medical technology, more effective and efficient COPD therapeutics are being developed. For example, inhalers with digital sensors are now available, which can help patients manage their COPD better by tracking medication use and providing feedback on inhaler technique. These technological advancements are expected to increase the demand for COPD therapeutics and drive market growth. The Spanish government has implemented several initiatives to improve the management and treatment of COPD. For example, the government launched a national plan for COPD in 2018, which aims to improve the prevention, diagnosis, and treatment of the disease. These initiatives are expected to increase awareness of COPD and drive market growth.

Market Restraints

The market is highly competitive, with several established players and new entrants vying for market share. This competition can make it challenging for companies to differentiate themselves and maintain their market position. COPD treatment can be costly, especially for patients who require frequent hospitalizations and medication. The high cost of treatment can be a barrier for some patients to access necessary therapies, which can affect market growth. Some COPD medications can have side effects, such as headaches, dizziness, and nausea, which can reduce patient compliance and satisfaction with treatment. This can affect the demand for COPD therapeutics in the market. Although there are several treatment options available for COPD, they do not cure the disease and can only provide symptom relief. This limited efficacy can be a challenge for patients and physicians, leading to a demand for more effective therapies. Companies operating in the COPD therapeutics market in Spain must adhere to regulatory requirements and guidelines. Compliance with these regulations can be time-consuming and costly, which can affect market growth.

Competitive Landscape

Key Players

  • Bioiberica
  • Ferrer
  • Laboratorios Esteve
  • Chiesi España
  • Almirall
  • Astellas Pharma
  • AstraZeneca
  • Boehringer Ingelheim Pharmaceuticals
  • Novartis
  • Pfizer

Healthcare Policies and Regulatory Landscape

Spain has a national healthcare system, which is funded through taxes and provides universal coverage to all citizens and legal residents. The healthcare system in Spain is decentralized, with responsibility for healthcare management shared between the central government and the regional governments. National Plan for COPD 2018, the Spanish government launched a national plan for COPD, which aims to improve the prevention, diagnosis, and treatment of the disease. The plan includes measures to increase awareness of COPD, improve early detection, and optimize treatment options. The Spanish government regulates the prices of pharmaceuticals to ensure that they are affordable and accessible to all citizens. This regulation can affect the pricing of COPD therapeutics in the market. Spain has a health technology assessment (HTA) system in place, which evaluates the effectiveness and cost-effectiveness of new technologies, including pharmaceuticals. HTA can influence the reimbursement and adoption of COPD therapeutics in the market.

Reimbursement Scenario

The Spanish government regulates the reimbursement system for pharmaceuticals. Pharmaceutical companies must apply for reimbursement for their products, and the government evaluates the products' safety, efficacy, and cost-effectiveness before deciding on the level of reimbursement. The level of reimbursement for COPD therapeutics in Spain varies, but generally, it ranges from 30% to 100% of the cost. The reimbursement rate can depend on the type of medication, the patient's medical history, and the region. As mentioned earlier, healthcare management is decentralized in Spain, and the regional governments have some autonomy in healthcare policy. Therefore, the reimbursement system can vary between regions, with some regions offering more generous reimbursement policies than others. Overall, the reimbursement scenario for COPD therapeutics in Spain is generally favorable, with most treatments reimbursed.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Segmentation

By Drug Class

Bronchodilators: Bronchodilators are medications that help to relax the muscles around the airways, making it easier to breathe. These can be further classified as short-acting or long-acting bronchodilators.

Corticosteroids: Corticosteroids are anti-inflammatory medications that can help reduce swelling and inflammation in the airways. These can be used alone or in combination with bronchodilators.

Combination therapies: Combination therapies combine bronchodilators and corticosteroids in a single medication. These are often used for patients with more severe COPD.

Phosphodiesterase-4 inhibitors: Phosphodiesterase-4 inhibitors are medications that help to reduce inflammation and improve airflow in the lungs.

Others: Other medications that may be used to treat COPD include mucolytics, oxygen therapy, and vaccines for influenza and pneumococcal disease.

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 14 June 2023
Updated by: Dhruv Joshi

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter